Antimicrobial stewardship in NICUs of low- and lower-middle-income countries - A narrative review

Aditya Hemendra Bhatt1

  • 1Senior Resident in Neonatology, Department of Neonatology, Pramukhswami Medical College, Bhaikaka University, Karamsad, India.

Tropical Doctor
|May 30, 2026
PubMed

Insights

Reducing antibiotic use in neonatal intensive care units (NICUs) in low-resource settings did not increase infant mortality or sepsis recurrence. This approach helps combat antimicrobial resistance without compromising patient safety.

Area of Science:

  • Neonatal Health
  • Infectious Diseases
  • Antimicrobial Stewardship

Background:

  • Neonatal sepsis is a significant global health challenge, particularly in low- and lower-middle-income countries (LMICs).
  • Limited diagnostic capabilities in these regions often lead to empiric antibiotic use in neonatal intensive care units (NICUs).
  • Widespread empiric antibiotic use contributes to the growing problem of antimicrobial resistance.

Purpose of the Study:

  • To review existing literature on strategies aimed at reducing empiric antibiotic use in neonatal intensive care units (NICUs).
  • To assess the impact of reduced antibiotic exposure on neonatal outcomes, including mortality and sepsis recurrence.

Main Methods:

  • A systematic review of 19 reports was conducted.
  • The review focused on studies implementing interventions to decrease antibiotic usage in neonatal intensive care units (NICUs).
  • Outcomes analyzed included mortality, sepsis recurrence, necrotising enterocolitis, and re-admissions.

Main Results:

  • Reduced antibiotic use in neonatal intensive care units (NICUs) was not associated with increased mortality.
  • There was no significant increase in sepsis recurrence, necrotising enterocolitis, or re-admissions following antibiotic reduction.
  • These findings suggest that antimicrobial stewardship interventions are feasible and safe in LMICs.

Conclusions:

  • Strategies to curb empiric antibiotic use in neonatal intensive care units (NICUs) are effective and do not compromise patient safety.
  • Reducing unnecessary antibiotic exposure is crucial for combating antimicrobial resistance in neonatal populations.
  • Further implementation of antimicrobial stewardship programs in LMICs is warranted to address both sepsis burden and resistance.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...